Department of Health and Human Services
National Institutes of Health
Toggle navigation
Search
Home
About the Clinical Center
Clinical Trials & You
Participate in a Study
Referring a Patient
How to Search
Contact Us
Search the Studies
Go Back
Searched Result
64 Studies found from all possible combinations of your search terms. Select a protocol that you wish to review.
Protocol Number
Title
Protocol Status
Min-Max Age
Institute
Keywords
001085-D
Phase 2 Study of the PTH-Independent Effects of Encaleret on Mineral Homeostasis in Subjects with Post-Surgical Hypoparathyroidism (PSH)
Recruitment has not started
18-125 Years
NIDCR
Gland
001043-I
Evaluating the Genetics and Immunology of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome and Other Tonsil Disorders
Recruitment has not started
0-125 Years
NIAID
Gland
001004-C
A Phase 1b/2 Basket Study of ACR-368 as Monotherapy and in Combination with Gemcitabine in Adult Subjects with Platinum-Resistant Ovarian Carcinoma, Endometrial Adenocarcinoma, and Urothelial Carcinoma Based on Acrivon Oncosignature (R) Status
Participants currently recruited/enrolled
18-120 Years
NCI
Gland
000740-CH
A Phase 3 Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Chronocort in the Treatment of Participants Aged 16 Years and Over with Congenital Adrenal Hyperplasia
Enrolling by Invitation
18-125 Years
NICHD
Gland
000611-C
A Phase II Trial of Focal Ultrahypofractionated Stereotactic Radiation Therapy for the Treatment of Unifocal Prostate Cancer
Recruitment has not started
18-125 Years
NCI
Gland
000569-C
Clinical Study of Bioactivity of Low Dose Apalutamide in Prostate Cancer Patients Scheduled for Prostatectomy
Participants currently recruited/enrolled
18-125 Years
NCI
Gland
000560-N
Data Collection of Standard Care of Patients in the EMG Section
Participants currently recruited/enrolled
18-125 Years
NINDS
Sweat
000491-C
Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)
Participants currently recruited/enrolled
18-125 Years
NCI
Gland
000417-CC
Characterization of the Nociception Phenotype in Individuals with Intellectual Disability
Clinical hold/Recruitment or enrollment suspended
8-30 Years
CC
Sweat
000344-DK
Natural History Study of Parathyroid Disorders
Participants currently recruited/enrolled
0-125 Years
NIDDK
Gland
000310-CH
A Phase 1/2, First-in-Human, Open-Label, Dose-Escalation Study of the Safety and Efficacy of Gene Therapy for Congenital Adrenal Hyperplasia through Administration of an Adeno-Associated Virus (AAV) Serotype 5-Based Recombinant Vector Encoding the Human
Recruitment has not started
18-125 Years
NICHD
Gland
000303-C
A Prospective, Multi-Institutional Phase II Trial Evaluating Temozolomide Vs. Temozolomide and Olaparib For Advanced Pheochromocytoma And Paraganglioma
Participants currently recruited/enrolled
18-125 Years
NCI
Gland
000178-C
Hyperspectral Analysis of Sweat Metabolite Biometrics for Real-Time Detection of COVID-19
Participants currently recruited/enrolled
18-125 Years
NCI
Sweat
000094-N
An Observational Study of Neurologic Function After COVID -19 Infection
No longer recruiting/follow-up only
18-125 Years
NINDS
Sweat
20-N-0048
Corticotrophin-Releasing Hormone (CRH) Stimulation for 18F-FDG-PET Detection of Pituitary Adenoma in Cushing's Disease
Recruitment has not started
8-125 Years
NINDS
Gland
20-N-0019
The Effect of Vorinostat on ACTH Producing Pituitary Adenomas in Cushing's Disease
Participants currently recruited/enrolled
18-125 Years
NINDS
Gland
20-D-0131
Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sj(SqrRoot)(Delta)gren's Syndrome; a Phase Ib-IIa Placebo-controlled Clinical Trial and Associated Mechanistic Studies
Participants currently recruited/enrolled
18-75 Years
NIDCR
Gland
20-D-0094
Transmissibility and Viral Load of SARS-CoV-2 Through Oral Secretions
Completed Study; data analyses ongoing
18-125 Years
NIDCR
Gland
20-CH-0126
Data Collection Study of Pediatric and Adolescent Gynecology Conditions
Participants currently recruited/enrolled
0-125 Years
NICHD
Gland
20-C-0097
A Phase II, Open-Label Trial of Bintrafusp Alfa (M7824) in Subjects with Thymoma and Thymic Carcinoma
Participants currently recruited/enrolled
18-125 Years
NCI
Gland
19-DK-0066
The Evaluation and Management of Endocrine-Related Conditions and Physiology
Participants currently recruited/enrolled
18-90 Years
NIDDK
Gland
19-CH-0051
Long-Term Follow-UP of Survivors of Pediatric Cushing Disease
Participants currently recruited/enrolled
2-90 Years
NICHD
Gland
19-CH-0020
A Phase 1-2 Multi-Center Study to Assess the Efficacy and Safety of Abiraterone Acetate as Adjunctive Therapy in Pre-Pubescent Children with Classic 21-Hydroxylase Deficiency
Recruitment has not started
2-9 Years
NICHD
Gland
19-C-0104
A Phase II Multi-Institutional Trial to Evaluate Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer
Participants currently recruited/enrolled
18-125 Years
NCI
Gland
18-N-0140
Clinical Laboratory Evaluation of Chronic Autonomic Failure
Participants currently recruited/enrolled
18-125 Years
NINDS
Sweat
18-N-0133
Feasibility of Endosphenoidal Coil Placement for Imaging of the Sella During Transsphenoidal Surgery
Participants currently recruited/enrolled
18-125 Years
NINDS
Gland
18-D-0121
Natural History of Chronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy Controls
Participants currently recruited/enrolled
18-100 Years
NIDCR
Gland
18-CH-0031
Clinical and Molecular Characteristics of Primary Aldosteronism in Blacks
Participants currently recruited/enrolled
7-70 Years
NICHD
Gland
18-C-0076
Bicalutamide With or Without Metformin for Biochemical Recurrence in Prostate Cancer Patients (BIMET-1)
Completed Study; data analyses ongoing
18-85 Years
NCI
Gland
17-C-0109
18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancer
Enrolling by Invitation
18-125 Years
NCI
Gland
17-C-0087
Lu-177-DOTATATE (Lutathera) in Therapy of Inoperable Pheochromocytoma/ Paraganglioma
Participants currently recruited/enrolled
18-125 Years
NCI
Gland
17-C-0066
A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma after Progression on Platinum-Based Chemotherapy
Participants currently recruited/enrolled
18-125 Years
NCI
Gland
17-C-0061
Phase II Trial of Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer
Completed Study; data analyses ongoing
18-125 Years
NCI
Gland
17-AT-0155
Sociocultural & Biobehavioral Influences on Pain Expression and Assessment
Participants currently recruited/enrolled
18-60 Years
NCCIH
Sweat
16-N-0058
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Completed Study; data analyses ongoing
18-60 Years
NINDS
Sweat
16-DK-0125
Evaluation of Adults with Endocrine-Related Conditions
Participants currently recruited/enrolled
18-100 Years
NIDDK
Gland
16-CH-0113
Evaluation of Children with Endocrine and Metabolic-Related Conditions
Participants currently recruited/enrolled
0-100 Years
NICHD
Gland
16-AT-0077
Clinical and Scientific Assessment of Pain and Painful Disorders
Participants currently recruited/enrolled
12-125 Years
NCCIH
Sweat
15-EI-0202
Evaluation of Oral Minocycline in the Treatment of Geographic Atrophy Associated with Age-Related Macular Degeneration
No longer recruiting/follow-up only
55-125 Years
NEI
Gland
15-D-0129
Open-Label, Dose-Escalation Study Evaluating the Safety of a Single Administration of an Adeno-Associated Virus Vector Encoding Human Aquaporin-1 to One Parotid Salivary Gland in Individuals with Irradiation-Induced Parotid Salivary Hypofunction.
Participants currently recruited/enrolled
18-125 Years
NIDCR
Gland
15-D-0051
Characterization of Diseases with Salivary Gland Involvement
Participants currently recruited/enrolled
4-125 Years
NIDCR
Gland
15-AT-0132
Neural and Psychological Mechanisms of Pain Perception
Participants currently recruited/enrolled
18-50 Years
NCCIH
Sweat
12-E-0050
The Role of Gonadotropin Pulsations in the Regulation of Puberty and Fertility
Participants currently recruited/enrolled
14-125 Years
NIEHS
Gland
12-C-0178
Longitudinal Assessment and Natural History Study of Children and Adults with MEN2A or MEN2B with or without Medullary Thyroid Carcinoma
Participants currently recruited/enrolled
0-125 Years
NCI
Gland
11-H-0046
Cross-Sectional Characterization of Idiopathic Bronchiectasis
Completed Study; data analyses ongoing
18-125 Years
NHLBI
Sweat
11-D-0172
The Pathogenesis and Natural History of Sjogren's Syndrome
Participants currently recruited/enrolled
16-125 Years
NIDCR
Gland
11-CH-0078
Evaluation of Cortisol Resistance in Young Endurance-Trained and Elderly Men
Completed Study; data analyses ongoing
18-30 Years
NICHD
Gland
09-N-0010
Biomarkers of Risk of Parkinson Disease
Completed Study; data analyses ongoing
18-70 Years
NINDS
Sweat
09-C-0242
Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Participants currently recruited/enrolled
4-125 Years
NCI
Gland
08-EI-0102
Screening Protocol for the Evaluation and Diagnosis of Potential Research Participants
Participants currently recruited/enrolled
2-125 Years
NEI
Gland
07-H-0005
Pilot Study of Topical Dexamethasone 0.01% Solution for Prevention of Oral Chronic Graft Versus Host Disease
Completed Study; data analyses ongoing
12-110 Years
NHLBI
Gland
07-D-0016
Effects of PTH Replacement on Bone in Hypoparathyroidism
Completed Study; data analyses ongoing
18-70 Years
NIDCR
Gland
07-CH-0008
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Completed Study; data analyses ongoing
18-85 Years
NICHD
Gland
07-C-0107
A Randomized Phase II Trial Combining Vaccine Therapy with PROSTVAC /TRICOM and Flutamide, vs. Flutamide Alone in Men with Androgen Insensitive, Non Metastatic (D0.5) Prostate Cancer
Completed Study; data analyses ongoing
18-125 Years
NCI
Gland
06-H-0217
Genetic Disorders of Mucociliary Clearance
Completed Study; data analyses ongoing
2-65 Years
NHLBI
Sweat
04-C-0102
Hematologic Malignancy Biology Study
Enrolling by Invitation
1-75 Years
NCI
Gland
01-I-0202
Natural History, Genetics, Phenotype, and Treatment of Mycobacterial Infections
Participants currently recruited/enrolled
0-100 Years
NIAID
Sweat
01-DC-0228
Clinical and Molecular Analysis of Enlarged Vestibular Aqueducts
Completed Study; data analyses ongoing
0-99 Years
NIDCD
Gland
00-CH-0160
Clinical and Molecular Analysis of ACTH-Independent Steroid Hormone Production in Adrenocortical Tissue
Completed Study; data analyses ongoing
3-70 Years
NICHD
Gland
00-CH-0093
Diagnosis, Pathophysiology, and Molecular Biology of Pheochromocytoma and Paraganglioma
Participants currently recruited/enrolled
3-125 Years
NICHD
Gland
97-CH-0076
A Clinical and Genetic Investigation of Pituitary and HYPOTHALAMIC Tumors and Related Disorders
Participants currently recruited/enrolled
3-70 Years
NICHD
Gland
95-CH-0059
Definition of the Genotype and Clinical Phenotype of Primary Pigmented Nodular Adrenocortical Disease (PPNAD), Carney Complex, Peutz-Jeghers Syndrome and Related Conditions
Completed Study; data analyses ongoing
3-70 Years
NICHD
Gland
93-I-0063
Study of the Immunopathogenesis, Natural History, and Genetics of Autoimmune Lymphoproliferative Syndrome (ALPS) Associated with an Expansion of CD4-8-/TCR alpha/beta+ T Cells
Participants currently recruited/enrolled
0-99 Years
NIAID
Gland
78-HG-0093
Use of Cysteamine in the Treatment of Cystinosis
Participants currently recruited/enrolled
0-125 Years
NHGRI
Gland